期刊文献+

消旋聚乳酸/羟基磷灰石/脱钙骨基质材料支架的体外细胞相容性实验研究 被引量:1

Biocompatibility of PDLLA/HA/DBM with human osteoblasts co-cultured in vitro
下载PDF
导出
摘要 目的 研究一种新的骨替代材料———消旋聚乳酸 羟基磷灰石 脱钙骨基质 (PDLLA HA DBM)骨细胞界面形态 ,评价其生物相容性。方法 采用体外细胞培养技术 ,选用培养的人成骨细胞 ,通过光镜和扫描电镜等观察 ,了解细胞在材料中的生长情况和相互关系 ,并与消旋聚乳酸 (PDLLA)及脱钙骨 (DBM)相比较。结果 随着培养时间的延长 ,细胞在PDLLA HA DBM材料表面的密度增加 ,未见细胞死亡。细胞以锚状结构牢固地附着于材料表面 ,并分泌细胞外基质 ,覆盖并完全包裹材料颗粒。结论 PDLLA HA DBM与人成骨细胞能早期形成骨性结合界面 ,具有良好的生物相容性 ,可望成为一种新的具有前景的骨替代材料。 Objective To evaluate the osteocompatibility of poly(D,L lactic acid)/ hydroxyapatite/decalcified bone matrix (PDLLA/HA/DBM) and to compare the osteocompatibility with that of PDLLA and DBM. Methods The isolated human osteoblasts from the femoral head of patients were inoculated onto PDLLA/HA/DBM, PLA, and DBM. The interface between biomaterial and osteoblasts was investigated with phase contrast microscope and scanning electron microscope. Results Osteoblasts were attached tightly to the surface of biomaterial with an arched structure and had normal morphology. The extracellular collagenous matrix covered the surface of biomaterial and packed the granules of biomaterial completely. Conclusion PDLLA/HA/DBM can form osteointegrated interface at the early stage with good biocompability.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2003年第24期2216-2219,共4页 Journal of Third Military Medical University
基金 重庆市攻关项目 ( 2 0 0 3)~~
关键词 成骨细胞 生物相容性 细胞培养 消旋聚乳酸/羟基磷灰石/脱钙骨基质 osteoblast biocompatibility cell culture PDLLA/HA/DBM
  • 相关文献

参考文献5

二级参考文献12

  • 1[2]Rose FR, Oreffo RO. Bone tissue engineering:Hope vs hype. Biochem Biophys Res Commun, 2002; 292(1):1
  • 2[3]Mike T, Masaka K, Imai Y, et al. Experience with freeze-dried PGLA/HA/rhBMP-2 as a bone graft substitute. J Craniomaxillofac Surg, 2000;28(5):294
  • 3[5]Whang CH, Thomas KE, Healy A. A novel method to fabricate bioabsorble scaffold. Polymer, 1995; 36(4):837
  • 4[6]Rizzi SC, Heath DJ, Coombes AG, et al. Biodegradable polymer/hydroxyapatite composites:Surface analysis and initial attachment of human osteoblasts. J Biomed Mater Res, 2001; 55(4):475
  • 5[8]Giardino R, Aldini NN, Fini M, et al. Enhanced guided bone regeneration with a resorbable chamber containing demineralized bone matrix. J Trauma, 2002; 52(5):933
  • 6[9]Einhorn TA. The cell and molecular biology of fracture healing. Clin Orthop, 1998; 355:7
  • 7杜卓民,实用组织学技术(第2版),1998年,322页
  • 8金丹,裴国献,王前.骨髓基质细胞与生物活性玻璃陶瓷和聚乳酸生物相容性的实验研究[J].中国修复重建外科杂志,2000,14(1):39-43. 被引量:28
  • 9刘月辉,文三立,肖尊文.复合活性羟基磷灰石陶瓷的研制及其生物相容性研究[J].中国生物医学工程学报,2000,19(1):53-59. 被引量:20
  • 10叶招明,严世贵,杨迪生,范顺武,陶惠民,柴莹.颈胸段脊柱肿瘤的外科治疗[J].中华骨科杂志,2000,20(5):261-264. 被引量:16

共引文献46

同被引文献6

  • 1张士杰,裴庆国,潘可风,蒋欣泉,张秀丽.新型多孔PLGA/HA复合支架体外细胞相容性的实验研究[J].中国美容整形外科杂志,2007,18(2):98-101. 被引量:3
  • 2Lie Shen,Hui Yang,Jia Ying. Preparation and mechanical properties of carbon fiber reinforced hydroxyapatite/polylactide biocomposites[J].Journal of Materials Science:Materials in Medicine,2009,(11):2259-2265.
  • 3Neuendorf RE,Saiz E,Tomsia AP. Adhesion between biodegradable polymers and hydroxyaptite:relevance to synthetic bone-like materials and tissue engineering scaffolds[J].Acta Biomaterialia,2008,(05):1288-1296.
  • 4中华人民共和国国家技术监督局.GB/T 168865-2003.医疗器械生物学评价-第5部分:体外细胞毒性试验医疗器械生物学评价-第5部分:体外细胞毒性试验[S].北京:中国标准出版社,2003658-673.
  • 5Ham MF. In vitro study of biodegradation of a CoCralloy using a human cell culture model[J].Journal of Biomaterials Science:Polymer Edition,1995,(09):809-814.
  • 6Lewandrowski KU,Bondre SP,Wise DL. Enhanced bioactivity of a poly (propylene fumarate)bone graft substitute by augmentation with nano-hydroxyapatite[J].Biomedical Materials & Engineering,2003,(02):115-124.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部